 |
Oklahoma Administrative Code (Last Updated: March 11, 2021) |
 |
TITLE 450. Department of Mental Health and Substance Abuse Services |
|
Chapter 70. Standards and Criteria for Opioid Treatment Programs |
|
Subchapter 6. Substance Use Disorder Treatment Services |
|
Part 3. PHASES OF TREATMENT SERVICES |
SECTION 450:70-6-17. Service phases - Take home doses
Latest version.
- (a) The OTP shall have written policy and procedure describing practices in accordance with the principle that take-home doses of methadone and buprenorphine are a privilege given only to those individuals who will benefit from them and who have demonstrated responsibility in taking methadone or buprenorphine as prescribed including:(1) The requirement of time in treatment as outlined elsewhere in this rule shall be considered as a minimum reference point after which a patient may be considered for take-home privileges.(2) Programs must educate the patient regarding safe transportation and storage of methadone as well as emergency procedures in case of accidental ingestion.(3) Before take-home privileges are allowed, the patient must have a lock box for transportation of methadone and home storage.(4) The program shall address the responsibilities of patients granted take-home medications. The policies shall include methods of assuring patient's appropriate use and storage of medication.(5) The program shall address the disposal of take-home bottles for methadone to include;(A) Requiring take-home bottles to be returned to the OTP and to require labels to be intact and the consequences for not returning bottles described.(B) Allowing patient disposal of take-home bottles to include procedures to insure the ability of the OTP to check for diversion by requiring patients to submit used take-home bottles in "call backs".(6) Regardless of time in treatment, the medical director, using reasonable judgment, may deny or rescind the take-home medication privileges of a patient.(7) All take-home privileges shall be made according to the rules of this section regarding the patients' current phase of treatment.(b) Compliance with 450:70-6-17 may be determined by:(1) A review of policies and procedures,(2) Treatment records, and(3) Other facility documentation.